Abivax (AAVXF) Non-Current Assets (2021 - 2026)

Abivax has reported Non-Current Assets for 6 years, with the latest figure at $39.7 million in Q1 2026.

• On a quarterly basis, Non-Current Assets rose 10.16% year-over-year to $39.7 million in Q1 2026; TTM through Mar 2026 was $39.7 million, a 10.16% increase from a year earlier, with the FY2025 full-year figure at $38.5 million, up 4.33% from the prior year.
• Non-Current Assets was $39.7 million for Q1 2026 at Abivax, up from $38.5 million in the prior quarter.
• The five-year high for Non-Current Assets was $44.7 million in Q2 2024, with the low at $36.1 million in Q1 2025.
• Average Non-Current Assets over 5 years is $39.6 million, with a median of $38.5 million recorded in 2025.
• The sharpest annual moves came in 2024 and 2026: Non-Current Assets slipped 16.47% in 2024, then rose 10.16% in 2026.
• Over 5 years, Non-Current Assets stood at $40.2 million in 2022, then climbed by 10.09% to $44.2 million in 2023, then dropped by 16.47% to $36.9 million in 2024, then gained by 4.33% to $38.5 million in 2025, then increased by 3.08% to $39.7 million in 2026.
• The last three Non-Current Assets figures came in at $39.7 million (Q1 2026), $38.5 million (Q4 2025), and $38.3 million (Q3 2025), per Business Quant data.